Verition Fund Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,796
Closed -$223K 3823
2025
Q3
$223K Sell
15,796
-7,406
-32% -$115K ﹤0.01% 3435
2025
Q2
$446K Buy
+23,202
New +$362K ﹤0.01% 3003
2024
Q3
Sell
-4,905
Closed -$283K 3433
2024
Q2
$283K Buy
+4,905
New +$240K ﹤0.01% 2389
2024
Q1
Sell
-1,543
Closed -$125K 2916
2023
Q4
$125K Buy
+1,543
New +$126K ﹤0.01% 2124
2023
Q3
Sell
-947
Closed -$311K 2581
2023
Q2
$311K Buy
+947
New +$289K ﹤0.01% 1535

Other funds holding OM

Verition Fund Management's OM Position: Q4 2025 in Review

Verition Fund Management sold out of Outset Medical (OM) in Q4 2025, closing a stake of 15,796 shares — an estimated $223K sold.

Verition Fund Management first reported a position in OM in Q2 2023 and held it in 5 quarters. The position peaked at $446K in Q2 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Verition Fund Management reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 15,796 Outset Medical shares in Q4 2025, an estimated $223K.
  • Verition Fund Management first reported a position in Outset Medical in Q2 2023 and held it in 5 quarters.
  • Verition Fund Management's Outset Medical position peaked at $446K in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.